Takeda launches Edarbyclor

DEERFIELD, Ill. — Takeda Pharmaceutical has launched a drug for treating high blood pressure in adults, the company said.



Takeda announced the availability of Edarbyclor (azilsartan medoxomil and chlorthalidone), a once-daily tablet for the condition, also known as hypertension.



"February is American Hearth Month, and it's important to recognize that nearly 40% of hypertension patients are not at their blood pressure targets, putting them at increased cardiovascular risk," Takeda Pharmaceuticals U.S.A. president Douglas Cole said. "We're pleased to bring Edarbyclor to market and expand the Edarbi family of products to help appropriate patients with hypertension work towards reaching their blood pressure goals."

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.